Home/Filings/4/0001140361-24-041562
4//SEC Filing

GILMAN STEVEN C 4

Accession 0001140361-24-041562

CIK 0000887359other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:05 PM ET

Size

8.1 KB

Accession

0001140361-24-041562

Insider Transaction Report

Form 4
Period: 2024-09-18
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-18$13.05/sh+5,834$76,13416,834 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-09-18+5,83411,666 total
    Exercise: $13.05Exp: 2028-05-02Common Stock (5,834 underlying)
  • Sale

    Common Stock

    2024-09-18$45.54/sh5,834$265,68011,000 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
  • [F2]These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001379970

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:05 PM ET
Size
8.1 KB